美股异动 | 部分医药股上涨 礼来(LLY.US)涨超2%

Core Viewpoint - The Trump administration is planning a five-year pilot program to reimburse the costs of weight loss medications for certain Medicare and Medicaid beneficiaries, which has led to a rise in pharmaceutical stocks, particularly Eli Lilly and Novo Nordisk, both of which saw increases of over 2% [1] Group 1: Pharmaceutical Stocks - Eli Lilly (LLY.US) experienced a stock increase of over 2% following the announcement [1] - Novo Nordisk (NVO.US) also saw a stock rise of over 2% in response to the news [1]